References
- Abud, E.M., Ramirez, R.N., Martinez, E.S., Healy, L.M., Nguyen, C.H.H., Newman, S.A., Yeromin, A.V., Scarfone, V.M., Marsh, S.E., Fimbres, C., et al. (2017). iPSC-derived human microglia-like cells to study neurological diseases. Neuron 94, 278-293.e9. https://doi.org/10.1016/j.neuron.2017.03.042
- Baik, S.H., Kang, S., Lee, W., Choi, H., Chung, S., Kim, J.I., and Mook-Jung, I. (2019). A breakdown in metabolic reprogramming causes microglia dysfunction in Alzheimer's disease. Cell Metab. 30, 493-507.e6. https://doi.org/10.1016/j.cmet.2019.06.005
- Bales, K.R., Verina, T., Dodel, R.C., Du, Y., Altstiel, L., Bender, M., Hyslop, P., Johnstone, E.M., Little, S.P., Cummins, D.J., et al. (1997). Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition. Nat. Genet. 17, 263-264. https://doi.org/10.1038/ng1197-263
- Bell, R.D., Winkler, E.A., Singh, I., Sagare, A.P., Deane, R., Wu, Z., Holtzman, D.M., Betsholtz, C., Armulik, A., Sallstrom, J., et al. (2012). Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature 485, 512-516. https://doi.org/10.1038/nature11087
- Benarroch, E.E. (2008). Brain cholesterol metabolism and neurologic disease. Neurology 71, 1368-1373. https://doi.org/10.1212/01.wnl.0000333215.93440.36
- Bernardo, A. and Minghetti, L. (2006). PPAR-gamma agonists as regulators of microglial activation and brain inflammation. Curr. Pharm. Des. 12, 93-109. https://doi.org/10.2174/138161206780574579
- Camargo, N., Goudriaan, A., van Deijk, A.L.F., Otte, W.M., Brouwers, J.F., Lodder, H., Gutmann, D.H., Nave, K.A., Dijkhuizen, R.M., Mansvelder, H.D., et al. (2017). Oligodendroglial myelination requires astrocyte-derived lipids. PLoS Biol. 15, e1002605. https://doi.org/10.1371/journal.pbio.1002605
- Canter, R.G., Penney, J., and Tsai, L.H. (2016). The road to restoring neural circuits for the treatment of Alzheimer's disease. Nature 539, 187-196. https://doi.org/10.1038/nature20412
- Cantuti-Castelvetri, L., Fitzner, D., Bosch-Queralt, M., Weil, M.T., Su, M., Sen, P., Ruhwedel, T., Mitkovski, M., Trendelenburg, G., Lutjohann, D., et al. (2018). Defective cholesterol clearance limits remyelination in the aged central nervous system. Science 359, 684-688. https://doi.org/10.1126/science.aan4183
- Casey, C.S., Atagi, Y., Yamazaki, Y., Shinohara, M., Tachibana, M., Fu, Y., Bu, G., and Kanekiyo, T. (2015). Apolipoprotein E inhibits cerebrovascular pericyte mobility through a RhoA protein-mediated pathway. J. Biol. Chem. 290, 14208-14217. https://doi.org/10.1074/jbc.M114.625251
- Cheng-Hathaway, P.J., Reed-Geaghan, E.G., Jay, T.R., Casali, B.T., Bemiller, S.M., Puntambekar, S.S., von Saucken, V.E., Williams, R.Y., Karlo, J.C., Moutinho, M., et al. (2018). The Trem2 R47H variant confers loss-offunction-like phenotypes in Alzheimer's disease. Mol. Neurodegener. 13, 29. https://doi.org/10.1186/s13024-018-0262-8
- Chrast, R., Saher, G., Nave, K.A., and Verheijen, M.H.G. (2011). Lipid metabolism in myelinating glial cells: lessons from human inherited disorders and mouse models. J. Lipid Res. 52, 419-434. https://doi.org/10.1194/jlr.R009761
- Chu, C.S., Tseng, P.T., Stubbs, B., Chen, T.Y., Tang, C.H., Li, D.J., Yang, W.C., Chen, Y.W., Wu, C.K., Veronese, N., et al. (2018). Use of statins and the risk of dementia and mild cognitive impairment: a systematic review and meta-analysis. Sci. Rep. 8, 5804. https://doi.org/10.1038/s41598-018-24248-8
- Chung, W.S., Verghese, P.B., Chakraborty, C., Joung, J., Hyman, B.T., Ulrich, J.D., Holtzman, D.M., and Barres, B.A. (2016). Novel allele-dependent role for APOE in controlling the rate of synapse pruning by astrocytes. Proc. Natl. Acad. Sci. U. S. A. 113, 10186-10191. https://doi.org/10.1073/pnas.1609896113
- Churchward, M.A. and Todd, K.G. (2014). Statin treatment affects cytokine release and phagocytic activity in primary cultured microglia through two separable mechanisms. Mol. Brain 7, 85. https://doi.org/10.1186/s13041-014-0085-7
- Corder, E.H., Saunders, A.M., Strittmatter, W.J., Schmechel, D.E., Gaskell, P.C., Small, G.W., Roses, A.D., Haines, J.L., and Pericak-Vance, M.A. (1993). Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921-923. https://doi.org/10.1126/science.8346443
-
Cossec, J.C., Simon, A., Marquer, C., Moldrich, R.X., Leterrier, C., Rossier, J., Duyckaerts, C., Lenkei, Z., and Potier, M.C. (2010). Clathrin-dependent APP endocytosis and
$A{\beta}$ secretion are highly sensitive to the level of plasma membrane cholesterol. Biochim. Biophys. Acta 1801, 846-852. https://doi.org/10.1016/j.bbalip.2010.05.010 - Courtney, R. and Landreth, G.E. (2016). LXR regulation of brain cholesterol: from development to disease. Trends Endocrinol. Metab. 27, 404-414. https://doi.org/10.1016/j.tem.2016.03.018
- De Strooper, B. and Karran, E. (2016). The cellular phase of Alzheimer's disease. Cell 164, 603-615. https://doi.org/10.1016/j.cell.2015.12.056
- Dean, D.C., Hurley, S.A., Kecskemeti, S.R., O'Grady, J.P., Canda, C., Davenport-Sis, N.J., Carlsson, C.M., Zetterberg, H., Blennow, K., Asthana, S., et al. (2017). Association of amyloid pathology with myelin alteration in preclinical Alzheimer disease. JAMA Neurol. 74, 41-49. https://doi.org/10.1001/jamaneurol.2016.3232
- Deczkowska, A., Keren-Shaul, H., Weiner, A., Colonna, M., Schwartz, M., and Amit, I. (2018). Disease-associated microglia: a universal immune sensor of neurodegeneration. Cell 173, 1073-1081. https://doi.org/10.1016/j.cell.2018.05.003
- Di Paolo, G. and Kim, T.W. (2011). Linking lipids to Alzheimer's disease: cholesterol and beyond. Nat. Rev. Neurosci. 12, 284-296. https://doi.org/10.1038/nrn3012
- Djelti, F., Braudeau, J., Hudry, E., Dhenain, M., Varin, J., Bieche, I., Marquer, C., Chali, F., Ayciriex, S., Auzeil, N., et al. (2015). CYP46A1 inhibition, brain cholesterol accumulation and neurodegeneration pave the way for Alzheimer's disease. Brain 138, 2383-2398. https://doi.org/10.1093/brain/awv166
- Domingues, H.S., Portugal, C.C., Socodato, R., and Relvas, J.B. (2016). Oligodendrocyte, astrocyte, and microglia crosstalk in myelin development, damage, and repair. Front. Cell Dev. Biol. 4, 71.
- Fassbender, K., Simons, M., Bergmann, C., Stroick, M., Lutjohann, D., Keller, P., Runz, H., Kuhl, S., Bertsch, T., von Bergmann, K., et al. (2001). Simvastatin strongly reduces levels of Alzheimer's disease beta-amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. Proc. Natl. Acad. Sci. U. S. A. 98, 5856-5861. https://doi.org/10.1073/pnas.081620098
- Ferris, H.A., Perry, R.J., Moreira, G.V., Shulman, G.I., Horton, J.D., and Kahn, C.R. (2017). Loss of astrocyte cholesterol synthesis disrupts neuronal function and alters whole-body metabolism. Proc. Natl. Acad. Sci. U. S. A. 114, 1189-1194. https://doi.org/10.1073/pnas.1620506114
- Fukui, K., Ferris, H.A., and Kahn, C.R. (2015). Effect of cholesterol reduction on receptor signaling in neurons. J. Biol. Chem. 290, 26383-26392. https://doi.org/10.1074/jbc.M115.664367
- Hatters, D.M., Peters-Libeu, C.A., and Weisgraber, K.H. (2006). Apolipoprotein E structure: insights into function. Trends Biochem. Sci. 31, 445-454. https://doi.org/10.1016/j.tibs.2006.06.008
- Holtman, I.R., Skola, D., and Glass, C.K. (2017). Transcriptional control of microglia phenotypes in health and disease. J. Clin. Invest. 127, 3220-3229. https://doi.org/10.1172/JCI90604
- Holtzman, D.M., Bales, K.R., Wu, S., Bhat, P., Parsadanian, M., Fagan, A.M., Chang, L.K., Sun, Y., and Paul, S.M. (1999). Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer's disease. J. Clin. Invest. 103, R15-R21. https://doi.org/10.1172/JCI6179
- Holtzman, D.M., Fagan, A.M., Mackey, B., Tenkova, T., Sartorius, L., Paul, S.M., Bales, K., Ashe, K.H., Irizarry, M.C., and Hyman, B.T. (2000). Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model. Ann. Neurol. 47, 739-747. https://doi.org/10.1002/1531-8249(200006)47:6<739::AID-ANA6>3.0.CO;2-8
- Holtzman, D.M., Herz, J., and Bu, G. (2012). Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease. Cold Spring Harb. Perspect. Med. 2, a006312. https://doi.org/10.1101/cshperspect.a006312
-
Huang, Y.W.A., Zhou, B., Wernig, M., and Sudhof, T.C. (2017). ApoE2, ApoE3, and ApoE4 differentially stimulate APP transcription and
$A{\beta}$ secretion. Cell 168, 427-441.e21. https://doi.org/10.1016/j.cell.2016.12.044 - Ingolfsson, H.I., Carpenter, T.S., Bhatia, H., Bremer, P.T., Marrink, S.J., and Lightstone, F.C. (2017). Computational lipidomics of the neuronal plasma membrane. Biophys. J. 113, 2271-2280. https://doi.org/10.1016/j.bpj.2017.10.017
- Jiang, X., Guo, M., Su, J., Lu, B., Ma, D., Zhang, R., Yang, L., Wang, Q., Ma, Y., and Fan, Y. (2012). Simvastatin blocks blood-brain barrier disruptions induced by elevated cholesterol both in vivo and in vitro. Int. J. Alzheimers Dis. 2012, 109324-109327.
- Kalayci, R., Kaya, M., Uzun, H., Bilgic, B., Ahishali, B., Arican, N., Elmas, I., and Kucuk, M. (2009). Influence of hypercholesterolemia and hypertension on the integrity of the blood-brain barrier in rats. Int. J. Neurosci. 119, 1881-1904. https://doi.org/10.1080/14647270802336650
- Kalvodova, L., Kahya, N., Schwille, P., Ehehalt, R., Verkade, P., Drechsel, D., and Simons, K. (2005). Lipids as modulators of proteolytic activity of BACE: involvement of cholesterol, glycosphingolipids, and anionic phospholipids in vitro. J. Biol. Chem. 280, 36815-36823. https://doi.org/10.1074/jbc.M504484200
- Karch, C.M. and Goate, A.M. (2015). Alzheimer's disease risk genes and mechanisms of disease pathogenesis. Biol. Psychiatry 77, 43-51. https://doi.org/10.1016/j.biopsych.2014.05.006
- Keren-Shaul, H., Spinrad, A., Weiner, A., Matcovitch-Natan, O., Dvir-Szternfeld, R., Ulland, T.K., David, E., Baruch, K., Lara-Astaiso, D., Toth, B., et al. (2017). A unique microglia type associated with restricting development of Alzheimer's disease. Cell 169, 1276-1290.e17. https://doi.org/10.1016/j.cell.2017.05.018
-
Kim, J., Jiang, H., Park, S., Eltorai, A.E.M., Stewart, F.R., Yoon, H., Basak, J.M., Finn, M.B., and Holtzman, D.M. (2011). Haploinsufficiency of human APOE reduces amyloid deposition in a mouse model of amyloid-
${\beta}$ amyloidosis. J. Neurosci. 31, 18007-18012. https://doi.org/10.1523/JNEUROSCI.3773-11.2011 - Kim, J., Yoon, H., Basak, J., and Kim, J. (2014). Apolipoprotein E in synaptic plasticity and Alzheimer's disease: potential cellular and molecular mechanisms. Mol. Cells 37, 767-776. https://doi.org/10.14348/molcells.2014.0248
- Koistinaho, M., Lin, S., Wu, X., Esterman, M., Koger, D., Hanson, J., Higgs, R., Liu, F., Malkani, S., Bales, K.R., et al. (2004). Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides. Nat. Med. 10, 719-726. https://doi.org/10.1038/nm1058
- Koudinov, A.R. and Koudinova, N.V. (2002). Cholesterol's role in synapse formation. Science 295, 2213. https://doi.org/10.1126/science.295.5563.2213a
- Krasemann, S., Madore, C., Cialic, R., Baufeld, C., Calcagno, N., El Fatimy, R., Beckers, L., O'Loughlin, E., Xu, Y., Fanek, Z., et al. (2017). The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity 47, 566-581.e9. https://doi.org/10.1016/j.immuni.2017.08.008
-
Kunkle, B.W., Grenier-Boley, B., Sims, R., Bis, J.C., Damotte, V., Naj, A.C., Boland, A., Vronskaya, M., van der Lee, S.J., Amlie-Wolf, A., et al. (2019). Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates
$A{\beta}$ , tau, immunity and lipid processing. Nat. Genet. 51, 414-430. https://doi.org/10.1038/s41588-019-0358-2 - Lambert, J.C., Ibrahim-Verbaas, C.A., Harold, D., Naj, A.C., Sims, R., Bellenguez, C., DeStafano, A.L., Bis, J.C., Beecham, G.W., Grenier-Boley, B., et al. (2013). Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat. Genet. 45, 1452-1458. https://doi.org/10.1038/ng.2802
-
Lee, C.Y.D., Tse, W., Smith, J.D., and Landreth, G.E. (2012). Apolipoprotein E promotes
${\beta}$ -amyloid trafficking and degradation by modulating microglial cholesterol levels. J. Biol. Chem. 287, 2032-2044. https://doi.org/10.1074/jbc.M111.295451 -
Li, Y., Liu, Q., Sun, J., Wang, J., Liu, X., and Gao, J. (2018). Mitochondrial protective mechanism of simvastatin protects against amyloid
${\beta}$ peptideinduced injury in SH-SY5Y cells. Int. J. Mol. Med. 41, 2997-3005. - Lin, Y.T., Seo, J., Gao, F., Feldman, H.M., Wen, H.L., Penney, J., Cam, H.P., Gjoneska, E., Raja, W.K., Cheng, J., et al. (2018). APOE4 causes widespread molecular and cellular alterations associated with Alzheimer's disease phenotypes in human iPSC-derived brain cell types. Neuron 98, 1141-1154.e7. https://doi.org/10.1016/j.neuron.2018.05.008
- Linetti, A., Fratangeli, A., Taverna, E., Valnegri, P., Francolini, M., Cappello, V., Matteoli, M., Passafaro, M., and Rosa, P. (2010). Cholesterol reduction impairs exocytosis of synaptic vesicles. J. Cell. Sci. 123, 595-605. https://doi.org/10.1242/jcs.060681
- Liu, C.C., Liu, C.C., Kanekiyo, T., Xu, H., and Bu, G. (2013). Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat. Rev. Neurol. 9, 106-118. https://doi.org/10.1038/nrneurol.2012.263
- Liu, C.C., Zhao, N., Fu, Y., Wang, N., Linares, C., Tsai, C.W., and Bu, G. (2017). ApoE4 accelerates early seeding of amyloid pathology. Neuron 96, 1024-1032.e3. https://doi.org/10.1016/j.neuron.2017.11.013
- Marquer, C., Devauges, V., Cossec, J.C., Liot, G., Lecart, S., Saudou, F., Duyckaerts, C., Leveque-Fort, S., and Potier, M.C. (2011). Local cholesterol increase triggers amyloid precursor protein-Bace1 clustering in lipid rafts and rapid endocytosis. FASEB J. 25, 1295-1305. https://doi.org/10.1096/fj.10-168633
- Marquer, C., Laine, J., Dauphinot, L., Hanbouch, L., Lemercier-Neuillet, C., Pierrot, N., Bossers, K., Le, M., Corlier, F., Benstaali, C., et al. (2014). Increasing membrane cholesterol of neurons in culture recapitulates Alzheimer's disease early phenotypes. Mol. Neurodegener. 9, 60. https://doi.org/10.1186/1750-1326-9-60
- Martin-Segura, A., Ahmed, T., Casadome-Perales, A., Palomares-Perez, I., Palomer, E., Kerstens, A., Munck, S., Balschun, D., and Dotti, C.G. (2019). Age-associated cholesterol reduction triggers brain insulin resistance by facilitating ligand-independent receptor activation and pathway desensitization. Aging Cell 18, e12932. https://doi.org/10.1111/acel.12932
- Mathys, H., Adaikkan, C., Gao, F., Young, J.Z., Manet, E., Hemberg, M., De Jager, P.L., Ransohoff, R.M., Regev, A., and Tsai, L.H. (2017). Temporal tracking of microglia activation in neurodegeneration at single-cell resolution. Cell Rep. 21, 366-380. https://doi.org/10.1016/j.celrep.2017.09.039
- Mathys, H., Davila-Velderrain, J., Peng, Z., Gao, F., Mohammadi, S., Young, J.Z., Menon, M., He, L., Abdurrob, F., Jiang, X., et al. (2019). Single-cell transcriptomic analysis of Alzheimer's disease. Nature 570, 332-337. https://doi.org/10.1038/s41586-019-1195-2
- Muffat, J., Li, Y., Yuan, B., Mitalipova, M., Omer, A., Corcoran, S., Bakiasi, G., Tsai, L.H., Aubourg, P., Ransohoff, R.M., et al. (2016). Efficient derivation of microglia-like cells from human pluripotent stem cells. Nat. Med. 22, 1358-1367. https://doi.org/10.1038/nm.4189
- Nieweg, K., Schaller, H., and Pfrieger, F.W. (2009). Marked differences in cholesterol synthesis between neurons and glial cells from postnatal rats. J. Neurochem. 109, 125-134. https://doi.org/10.1111/j.1471-4159.2009.05917.x
- Nishitsuji, K., Hosono, T., Nakamura, T., Bu, G., and Michikawa, M. (2011). Apolipoprotein E regulates the integrity of tight junctions in an isoformdependent manner in an in vitro blood-brain barrier model. J. Biol. Chem. 286, 17536-17542. https://doi.org/10.1074/jbc.M111.225532
- Nuriel, T., Angulo, S.L., Khan, U., Ashok, A., Chen, Q., Figueroa, H.Y., Emrani, S., Liu, L., Herman, M., Barrett, G., et al. (2017). Neuronal hyperactivity due to loss of inhibitory tone in APOE4 mice lacking Alzheimer's disease-like pathology. Nat. Commun. 8, 1464. https://doi.org/10.1038/s41467-017-01444-0
- O'Brien, R.J. and Wong, P.C. (2011). Amyloid precursor protein processing and Alzheimer's disease. Annu. Rev. Neurosci. 34, 185-204. https://doi.org/10.1146/annurev-neuro-061010-113613
- Palop, J.J. and Mucke, L. (2010). Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks. Nat. Neurosci. 13, 812-818. https://doi.org/10.1038/nn.2583
- Pandya, H., Shen, M.J., Ichikawa, D.M., Sedlock, A.B., Choi, Y., Johnson, K.R., Kim, G., Brown, M.A., Elkahloun, A.G., Maric, D., et al. (2017). Differentiation of human and murine induced pluripotent stem cells to microglia-like cells. Nat. Neurosci. 20, 753-759. https://doi.org/10.1038/nn.4534
- Pappolla, M.A., Bryant-Thomas, T.K., Herbert, D., Pacheco, J., Fabra Garcia, M., Manjon, M., Girones, X., Henry, T.L., Matsubara, E., Zambon, D., et al. (2003). Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology. Neurology 61, 199-205. https://doi.org/10.1212/01.WNL.0000070182.02537.84
- Parhizkar, S., Arzberger, T., Brendel, M., Kleinberger, G., Deussing, M., Focke, C., Nuscher, B., Xiong, M., Ghasemigharagoz, A., Katzmarski, N., et al. (2019). Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE. Nat. Neurosci. 22, 191-204. https://doi.org/10.1038/s41593-018-0296-9
-
Park, S.H., Kim, J.H., Choi, K.H., Jang, Y.J., Bae, S.S., Choi, B.T., and Shin, H.K. (2013). Hypercholesterolemia accelerates amyloid
${\beta}$ -induced cognitive deficits. Int. J. Mol. Med. 31, 577-582. https://doi.org/10.3892/ijmm.2013.1233 - Pfrieger, F.W. and Ungerer, N. (2011). Cholesterol metabolism in neurons and astrocytes. Prog. Lipid Res. 50, 357-371. https://doi.org/10.1016/j.plipres.2011.06.002
- Rackova, L. (2013). Cholesterol load of microglia: contribution of membrane architecture changes to neurotoxic power? Arch. Biochem. Biophys. 537, 91-103. https://doi.org/10.1016/j.abb.2013.06.015
- Ricote, M., Valledor, A.F., and Glass, C.K. (2004). Decoding transcriptional programs regulated by PPARs and LXRs in the macrophage: effects on lipid homeostasis, inflammation, and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 24, 230-239. https://doi.org/10.1161/01.ATV.0000103951.67680.B1
- Saher, G., Brugger, B., Lappe-Siefke, C., Möbius, W., Tozawa, R.I., Wehr, M.C., Wieland, F., Ishibashi, S., and Nave, K.A. (2005). High cholesterol level is essential for myelin membrane growth. Nat. Neurosci. 8, 468-475. https://doi.org/10.1038/nn1426
- Saijo, K., Crotti, A., and Glass, C.K. (2013). Regulation of microglia activation and deactivation by nuclear receptors. Glia 61, 104-111. https://doi.org/10.1002/glia.22423
- Savage, J.C., Jay, T., Goduni, E., Quigley, C., Mariani, M.M., Malm, T., Ransohoff, R.M., Lamb, B.T., and Landreth, G.E. (2015). Nuclear receptors license phagocytosis by trem2+ myeloid cells in mouse models of Alzheimer's disease. J. Neurosci. 35, 6532-6543. https://doi.org/10.1523/JNEUROSCI.4586-14.2015
- Selkoe, D.J. and Hardy, J. (2016). The amyloid hypothesis of Alzheimer's disease at 25 years. EMBO Mol. Med. 8, 595-608. https://doi.org/10.15252/emmm.201606210
- Shi, Y., Yamada, K., Liddelow, S.A., Smith, S.T., Zhao, L., Luo, W., Tsai, R.M., Spina, S., Grinberg, L.T., Rojas, J.C., et al. (2017). ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy. Nature 549, 523-527. https://doi.org/10.1038/nature24016
- Simons, M., Keller, P., De Strooper, B., Beyreuther, K., Dotti, C.G., and Simons, K. (1998). Cholesterol depletion inhibits the generation of betaamyloid in hippocampal neurons. Proc. Natl. Acad. Sci. U. S. A. 95, 6460-6464. https://doi.org/10.1073/pnas.95.11.6460
- Sinha, S. and Lieberburg, I. (1999). Cellular mechanisms of beta-amyloid production and secretion. Proc. Natl. Acad. Sci. U. S. A. 96, 11049-11053. https://doi.org/10.1073/pnas.96.20.11049
- Strittmatter, W.J., Saunders, A.M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G.S., and Roses, A.D. (1993). Apolipoprotein E: highavidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 90, 1977-1981. https://doi.org/10.1073/pnas.90.5.1977
-
Tai, L.M., Youmans, K.L., Jungbauer, L., Yu, C., and Ladu, M.J. (2011). Introducing human APOE into
$A{\beta}$ transgenic mouse models. Int. J. Alzheimers Dis. 2011, 810981. -
TCW, J., Liang, S.A., Qian, L., Pipalia, N.H., Chao, M.J., Shi, Y., Bertelsen, S.E., Kapoor, M., Marcora, E., Sikora, E., et al. (2019). Cholesterol and matrisome pathways dysregulated in human APOE
${\varepsilon}4$ glia. bioRxiv 99, 713362. - Tong, J., Borbat, P.P., Freed, J.H., and Shin, Y.K. (2009). A scissors mechanism for stimulation of SNARE-mediated lipid mixing by cholesterol. Proc. Natl. Acad. Sci. U. S. A. 106, 5141-5146. https://doi.org/10.1073/pnas.0813138106
- Ulrich, J.D., Ulland, T.K., Mahan, T.E., Nyström, S., Nilsson, K.P., Song, W.M., Zhou, Y., Reinartz, M., Choi, S., Jiang, H., et al. (2018). ApoE facilitates the microglial response to amyloid plaque pathology. J. Exp. Med. 215, 1047-1058. https://doi.org/10.1084/jem.20171265
- van Deijk, A.F., Camargo, N., Timmerman, J., Heistek, T., Brouwers, J.F., Mogavero, F., Mansvelder, H.D., Smit, A.B., and Verheijen, M.H. (2017). Astrocyte lipid metabolism is critical for synapse development and function in vivo. Glia 65, 670-682. https://doi.org/10.1002/glia.23120
- Vance, J.E. (2012). Dysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseases. Dis. Model Mech. 5, 746-755. https://doi.org/10.1242/dmm.010124
- Voskuhl, R.R., Itoh, N., Tassoni, A., Matsukawa, M.A., Ren, E., Tse, V., Jang, E., Suen, T.T., and Itoh, Y. (2019). Gene expression in oligodendrocytes during remyelination reveals cholesterol homeostasis as a therapeutic target in multiple sclerosis. Proc. Natl. Acad. Sci. U. S. A. 116, 10130-10139. https://doi.org/10.1073/pnas.1821306116
- Wingo, T.S., Cutler, D.J., Wingo, A.P., Le, N.A., Rabinovici, G.D., Miller, B.L., Lah, J.J., and Levey, A.I. (2019). Association of early-onset Alzheimer disease with elevated low-density lipoprotein cholesterol levels and rare genetic coding variants of APOB. JAMA Neurol. 76, 809-817. https://doi.org/10.1001/jamaneurol.2019.0648
- Wood, W.G., Li, L., Muller, W.E., and Eckert, G.P. (2014). Cholesterol as a causative factor in Alzheimer's disease: a debatable hypothesis. J. Neurochem. 129, 559-572. https://doi.org/10.1111/jnc.12637
- Wu, L., Zhang, X., and Zhao, L. (2018). Human ApoE isoforms differentially modulate brain glucose and ketone body metabolism: implications for Alzheimer's disease risk reduction and early intervention. J. Neurosci. 38, 6665-6681. https://doi.org/10.1523/JNEUROSCI.2262-17.2018
- Wu, Y., Ma, Y., Liu, Z., Geng, Q., Chen, Z., and Zhang, Y. (2017). Alterations of myelin morphology and oligodendrocyte development in early stage of Alzheimer's disease mouse model. Neurosci. Lett. 642, 102-106. https://doi.org/10.1016/j.neulet.2017.02.007
- Xu, Q., Bernardo, A., Walker, D., Kanegawa, T., Mahley, R.W., and Huang, Y. (2006). Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus. J. Neurosci. 26, 4985-4994. https://doi.org/10.1523/JNEUROSCI.5476-05.2006
- Zhang, Y., Chen, K., Sloan, S.A., Bennett, M.L., Scholze, A.R., O'Keeffe, S., Phatnani, H.P., Guarnieri, P., Caneda, C., Ruderisch, N., et al. (2014). An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J. Neurosci. 34, 11929-11947. https://doi.org/10.1523/JNEUROSCI.1860-14.2014
- Zhang, Y., Sloan, S.A., Clarke, L.E., Caneda, C., Plaza, C.A., Blumenthal, P.D., Vogel, H., Steinberg, G.K., Edwards, M.S.B., Li, G., et al. (2016). Purification and characterization of progenitor and mature human astrocytes reveals transcriptional and functional differences with mouse. Neuron 89, 37-53. https://doi.org/10.1016/j.neuron.2015.11.013
Cited by
- Low-Density Lipoprotein Cholesterol and Alzheimer's Disease: A Systematic Review and Meta-Analysis vol.12, 2019, https://doi.org/10.3389/fnagi.2020.00005
- Steroids and Alzheimer’s Disease: Changes Associated with Pathology and Therapeutic Potential vol.21, pp.13, 2019, https://doi.org/10.3390/ijms21134812
- A Coordinated Approach by Public Domain Bioinformatics Resources to Aid the Fight Against Alzheimer’s Disease Through Expert Curation of Key Protein Targets vol.77, pp.1, 2020, https://doi.org/10.3233/jad-200206
- Plasma Lipids as Biomarkers for Alzheimer's Disease: A Systematic Review vol.12, pp.12, 2019, https://doi.org/10.7759/cureus.12008
- Insulin resistance: a connecting link between Alzheimer’s disease and metabolic disorder vol.36, pp.1, 2019, https://doi.org/10.1007/s11011-020-00622-2
- Uncovering Disease Mechanisms in a Novel Mouse Model Expressing Humanized APOEε4 and Trem2*R47H vol.13, 2021, https://doi.org/10.3389/fnagi.2021.735524
- Neurodegenerative Diseases and Cholesterol: Seeing the Field Through the Players vol.13, 2019, https://doi.org/10.3389/fnagi.2021.766587
- Could COVID-19 anosmia and olfactory dysfunction trigger an increased risk of future dementia in patients with ApoE4? vol.147, 2021, https://doi.org/10.1016/j.mehy.2020.110479
- Acetyl-CoA Metabolism and Histone Acetylation in the Regulation of Aging and Lifespan vol.10, pp.4, 2021, https://doi.org/10.3390/antiox10040572
- Plasma lipidome is dysregulated in Alzheimer’s disease and is associated with disease risk genes vol.11, pp.1, 2019, https://doi.org/10.1038/s41398-021-01362-2
- High-Fat and Resveratrol Supplemented Diets Modulate Adenosine Receptors in the Cerebral Cortex of C57BL/6J and SAMP8 Mice vol.13, pp.9, 2019, https://doi.org/10.3390/nu13093040
- Cholesterol Dysmetabolism in Alzheimer’s Disease: A Starring Role for Astrocytes? vol.10, pp.12, 2021, https://doi.org/10.3390/antiox10121890
- An evidence-based review of neuronal cholesterol role in dementia and statins as a pharmacotherapy in reducing risk of dementia vol.21, pp.12, 2019, https://doi.org/10.1080/14737175.2021.2003705